RUNX2 and neoplasm: Given that E-cadherin inhibited tumor cell invasion significantly more effectively in the SynG2/M phase than in the SynG1 and SynS phases, we wonder if its overexpression specifically deactivates the Fam50a/Runx2-MMP13 axis.